Evidence map›Paper›PMID 32739870›Full record

ArticleEBioMedicine2020

DNABII targeting antibodies as vaccines against biofilm diseases.

Marco M D'Andrea, Gee W Lau

Abstract readComment
In one paragraph

Article in EBioMedicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Imaging nucleic acids in biofilms.Essays in biochemistry · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. [Precision medicine in infectious diseases].Innere Medizin (Heidelberg, Germany) · 2024
    Review
  7. Review
  8. NontypeableBiofilm · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Marco M D'AndreaDepartment of Biology, University of Rome "Tor Vergata", 00133 Rome, Italy.
Gee W LauDepartment of Pathobiology, University of Illinois at Urbana-Champaign, Urbana, IL 61802, USA. Electronic address: geelau@illinois.edu.

Funding

Controlling bactermic pneumococcal pneumonia with synthetic dominant-negative competence peptidesR01HL142626 · NHLBI · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI LAU, GEE W, TALGAN, YIFTAH · 2019 to 2022
$2.0M
Mechanisms of Pseudomonas Resistance to Membrane Permeabilization by SP-AR01HL090699 · NHLBI · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI LAU, GEE W · 2009 to 2012
$1.6M
NHLBI NIH HHS R01 HL090699NHLBI NIH HHS R01 HL142626
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BiofilmsVaccinesAntibodiesBacterial ProteinsHumansAntibodiesBacterial ProteinsVaccines

Identifiers

PMID32739870
PMCPMC7393518

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.